David Millan - Concepedia

Author

David Millan

Also Known As

D MILLAN, D Millan, D W Millan, D. MILLAN, D. Millan, D. W. M. MILLAN, D. W. M. Millan, David Millan, David W. M. Millan, David W. Millan

Publications

Citations

H-Index

Concepts

All Affiliations

University of Glasgow Queen Elizabeth University Hospital Cancer Research UK Cancer Research UK Clinical Trials Unit Beatson West of Scotland Cancer Centre

About

David Millan is an author at University of Glasgow specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1.6K
2	Public Health	6	6	217
3	Engineering	1	1	53
4	Health Sciences	1	1	37
5	Natural Sciences	1	1	53

David Millan

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Copy number signatures and mutational processes in ovarian carcinoma Geoff Macintyre, Teodora Goranova, Dilrini De Silva, Nature Genetics Somatic VariantTumor HeterogeneityPathologyOvarian CancerCopy Number Signatures	2018	433
Mannose impairs tumour growth and enhances chemotherapy Pablo Sierra Gonzalez, James O’Prey, Simone Cardaci, Nature Tumor BiologyMannose ImpairsMalignant DiseaseMedicinePathology	2018	410
Primary Ovarian Carcinomas Display Multiple Methylator Phenotypes Involving Known Tumor Suppressor Genes Gordon Strathdee, Kim Appleton, Maureen Illand, American Journal Of Pathology MedicineGynecologyPathologyTumor SuppressorCancer Genetics	2001	202
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity Juan R. Hernández‐Fernaud, Elena Ruengeler, Andrea Casazza, Nature Communications Tumor BiologyOncologyCaf SecretomeOncogenic AgentMedicine	2017	113
Copy-number signatures and mutational processes in ovarian carcinoma Geoff Macintyre, Teodora Goranova, Dilrini De Silva, OncologySomatic VariantTumor HeterogeneityCopy-number SignaturesGenetics	2017	94
Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival Wei Dai, Jens M. Teodoridis, Constanze Zeller, Clinical Cancer Research	2011	88
Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system Edgar Petru, H.-J. Lück, Gavin Stuart, European Journal of Obstetrics & Gynecology and Reproductive Biology Cancer DetectionMedicineGynecologic Cancer IntergroupGynecologyOncology	2009	82
RNA splicing factors regulated by HPV16 during cervical tumour progression Sarah Mole, Melanie McFarlane, Thanaporn Chuen‐Im, The Journal of Pathology Transcriptional RegulationSystems BiologyCervical CancerTranscription RegulationCervical Tumour	2009	76
HPV status and favourable outcome in vulvar squamous cancer Katie Wakeham, Kimberley Kavanagh, Kate Cuschieri, International Journal of Cancer GynecologyPathologyHpv InfectionCytopathologyOral Cancer	2016	76
Squamous carcinoma following lichen planus of the vulva C. M. Dwyer, R. E. I. KERR, David Millan Clinical and Experimental Dermatology Tumoral PathologyVulvar DiseasesLichenSquamous CarcinomaMedicine	1995	68

Page 1